Showing 1381 - 1390 of 1412 for "PTAB litigation" with applied filters
Filters:
23 November 2018 by Ilya Kazi
Ilya Kazi and Miranda Kent of Mathys & Squire analyse the changes to the EPO’s opposition procedure and suggest ways in which businesses can align their strategy with the current legal tools available
13 November 2018 by Managing Intellectual Property
Firm gains post-grant proceedings specialist in Orange County
31 October 2018 by Kingsley Egbuonu
This roundup includes Nelson Mullins Broad and Cassel, Kilpatrick Townsend & Stockton, Venable, Kacvinsky Daisak Bluni, Oblon, Shearman & Sterling, Alessandri, Maucher Jenkins, Hoyng Rokh Monegier, AWA, Venner Shipley, Mewburn Ellis, Page White and Farrer, Bird & Bird, Dittmar & Indrenius, Mathys & Squire, Baker McKenzie Habib Al Mulla, and Simone Intellectual Property Services Asia (SIPS).
21 September 2018 by Managing Intellectual Property
Managing Intellectual Property hosted a well-attended webinar yesterday to provide information about IP STARS and the research for the 2019 edition. Questions from attendees were also answered.
01 September 2018 by Stefanie Parchmann
At last, Germany has clear guidelines regarding the litigation value of an appeal to the German Federal High Court of Justice (BGH)
01 September 2018 by Lakshmikumaran & Sridharan
In a judgment dated July 12 2018, the Delhi High Court has allowed a plea of patent infringement by Koninklijke Philips Electronics (Phillips)
01 September 2018 by ABE & Partners
The Japanese IP system has vulnerable evidence collection procedures in comparison with foreign countries.
01 September 2018 by Managing Intellectual Property
Early this year, the Mexican Institute of Industrial Property issued decisions denying registration for the trade mark PINCHE GRINGO BBQ & Design in classes 43 (restaurants) and 30 (sauces)
01 September 2018 by Norton Rose Fulbright
Big names in Hollywood, sports, and music often enforce their personality rights
02 July 2018 by Takanori Abe
Shionogi is the owner of a patent entitled Pyrimidine Derivatives (JP2648897). X filed a request for a trial for invalidation of the patent. Nippon Chemiphar intervened in the trial as a plaintiff, and AstraZeneca UK intervened in the trial in order to support the defendant.
